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Abstract
Background
Children are substantially affected by enteric fever in most settings with a high burden of the
disease, including Nepal. However pathogen population structure and transmission dynam-
ics are poorly delineated in young children, the proposed target group for immunization pro-
grams. Here we present whole genome sequencing and antimicrobial susceptibility data on
198 S. Typhi and 66 S. Paratyphi A isolated from children aged 2 months to 15 years of age
during blood culture surveillance at Patan Hospital, Nepal, 2008–2016.
Principal findings
S. Typhi was the dominant agent and comprised several distinct genotypes, dominated by
4.3.1 (H58). The heterogeneity of genotypes in children under five was reduced compared
to data from 2005–2006, attributable to ongoing clonal expansion of H58. Most isolates
(86%) were non-susceptible to fluoroquinolones, associated mainly with S. Typhi H58
lineage II and S. Paratyphi A harbouring mutations in the quinolone resistance-determining
region (QRDR); non-susceptible strains from these groups accounted for 50% and 25% of
all isolates. Multi-drug resistance (MDR) was rare (3.5% of S. Typhi, 0 S. Paratyphi A) and
restricted to chromosomal insertions of resistance genes in H58 lineage I strains. Temporal
analyses revealed a shift in dominance from H58 Lineage I to H58 Lineage II, with the latter
being significantly more common after 2010. Comparison to global data sets showed the
local S. Typhi and S. Paratyphi A strains had close genetic relatives in other South Asian
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countries, indicating regional strain circulation. Multiple imports from India of ciprofloxacin-
resistant H58 lineage II strains were identified, but these were rare and showed no evidence
of clonal replacement of local S. Typhi.
Significance
These data indicate that enteric fever in Nepal continues to be a major public health issue
with ongoing inter- and intra-country transmission, and highlights the need for regional coor-
dination of intervention strategies. The absence of a S. Paratyphi A vaccine is cause for con-
cern, given its prevalence as a fluoroquinolone resistant enteric fever agent in this setting.
Introduction
As in most developing countries, invasive bacterial infections account for a significant propor-
tion of paediatric morbidity and mortality in Nepal[1,2]. Enteric fever, caused by Salmonella
enterica serovars Typhi (S. Typhi) and Paratyphi A (S. Paratyphi A), is the most common
cause of bloodstream infection in Nepal[1,2] and on a global scale causes an estimated 26 mil-
lion cases of enteric fever annually of which a large proportion are in children[3,4]. In Nepal, it
is estimated that 13% of febrile paediatric cases attending outpatient care are blood culture
positive for S. Typhi or Paratyphi A[2]. Single nucleotide polymorphism (SNP) genotyping of
S. Typhi isolated in a study of paediatric enteric fever cases at Patan Hospital in Kathmandu,
Nepal during 2005 and 2006 suggested that, among children treated as inpatients, those aged
4 years were susceptible to a wider range of haplotypes due to immune naivety[5]. The most
common genotype was H58 lineage II (70%), followed by H42 (19%)[5]. Another study of
adults and children at Patan Hospital from 2005 to 2009 found that 26% of culture-positive
cases were associated with S. Paratyphi A; the rest were caused by S. Typhi, mainly H58 lineage
II (61%) or other H58 (3%), or H42 (15%)[6]. More recently, whole genome sequencing
(WGS) was applied to study S. Typhi isolates collected during a randomized controlled trial of
gatifloxacin vs ceftriaxone for treatment of blood culture confirmed enteric fever at Patan Hos-
pital between 2011 and 2014, and found the H58 genotype continued to dominate the circulat-
ing S. Typhi population (83%)[7].
Multi-drug resistant (MDR) S. Typhi, defined as resistant to the first-line antibiotics ampi-
cillin, chloramphenicol and co-trimoxazole, became common in the Indian subcontinent in
the 1990s[8], driven by the spread of H58 carrying an IncHI1 plasmid harbouring a suite of
antimicrobial resistance (AMR) genes[9]. These S. Typhi strains are still circulating in the
region, including in India, Pakistan and Bangladesh. In this setting there is also evidence of
migration of the MDR genes to the S. Typhi chromosome, and acquisition of resistance to flu-
oroquinolones and third-generation cephalosporins in MDR and non-MDR S. Typhi strain
backgrounds, which further limits treatment options in the region[10]. However in Nepal, the
MDR H58 S. Typhi appears to have been replaced by non-MDR H58 S. Typhi carrying the
S83F mutation in gyrA and other mutations in the quinolone resistance determining region
(QRDR) associated with reduced susceptibility to fluoroquinolones[5,6] and more recently the
introduction of fluoroquinolone resistant H58 S. Typhi ‘triple mutants’ harbouring three
QRDR mutations (gyrA S83F, gyrAD87V, and parC S80I), likely from India, resulting in fail-
ure of gatifloxacin treatment[7]. S. Paratyphi A in Nepal is generally not MDR, but frequently
carries fluoroquinolone non-susceptibility alleles in gyrA and parC.[11–13]
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Given the current treatment complexities of paediatric enteric fever, vaccination would
seem the most feasible short-term strategy. There is no vaccine against S. Paratyphi A, which
accounts for approximately a quarter of disease cases in Nepal. The Vi polysaccharide vaccine
against S. Typhi is not effective in children under two years of age[14], and has therefore not
been deployed as part of the national immunization schedule in Nepal and is only available
privately. While the Vi conjugate vaccines have the potential to reduce the incidence of enteric
fever in Nepal, the immunization approach and schedule needs to be clearly defined. This
study sheds light on the age distribution of affected inpatient children at Patan Hospital, and
the molecular structure and AMR determinants of circulating bacterial pathogen populations
causing paediatric enteric fever from 2008 to 2016 in Nepal, with the view of informing pre-
ventive strategies including vaccine policy.
Methods
Ethics statement
Ethical approval was obtained from the Oxford Tropical Research Ethics Committee
(OxTREC) as well as local institutional approval from the Nepal Health Research Council
(R31579/CN007).
Study setting
Nepal is a low income[15], landlocked Himalayan nation with an under-five year old mortality
rate of 35.8 per 1000 live births as of 2015[16]. Kathmandu Valley, the main urban centre of
Nepal, has three districts and a population of 2.5 million[17] (average population density:
2,372/km2) of which 31% are between 0–14 years under age[18]. Over the course of the study,
the Patan Academy of Health Sciences (PAHS) was one of only two large hospitals in Kath-
mandu Valley with referral and paediatric intensive care services. Patan Hospital accepts
patients from all over the Valley. Annually the paediatric department cares for over 50,000 out-
patients (21% of all hospital outpatient attendances) and accepts approximately 2,700 inpatient
admissions. Only 10% of the patients reside outside Kathmandu Valley.
Surveillance of culture confirmed enteric fever amongst inpatients
Febrile children under 14 years of age, attending PAHS with clinical suspicion of invasive bac-
terial disease between January 2008 and December 2016 were included in an invasive bacterial
disease database as described previously[19]. Inclusion criteria were: clinical presentation indi-
cating an invasive bacterial infection requiring inpatient care with intravenous antibiotics.
Blood culture was conducted as described below. Of the patients included in the database, all
those that had blood cultures positive for S. Typhi or S. Paratyphi A were included in the pres-
ent study, along with relevant demographic data. A total of 67/102 S. Typhi isolates and 17/27
S. Paratyphi A isolates from these patients had been stored, and were subjected to whole
genome sequencing; these represent isolates associated with paediatric enteric fever presenting
to the hospital, which may represent the more severe end of the spectrum of disease in the
community.
Isolates collected from outpatients
Children with milder clinical presentations who are usually treated with oral antibiotics as out-
patients were not included in the invasive bacterial disease database; however they are sub-
jected to the same microbiological diagnostic procedures as inpatients (as detailed below). A
total of 1283 S. Typhi and 926 S. Paratyphi A isolates from paediatric outpatients were stored
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between 2008 and 2016; every 10th S. Typhi isolate and every 5th S. Paratyphi A isolate were
included in this current study, representing isolates associated with milder presentation of pae-
diatric enteric fever at the hospital.
Blood culture processing
Aerobic blood culture bottles were used to culture 3–5 mL of blood, which were then incu-
bated in a BD Bactec FX 40 incubator at 37˚C for a maximum of 5 days. Turbid samples were
then inoculated directly onto MacConkey agar and incubated for maximum of 5 days at 37˚C
to identify potential S. Typhi and S. Paratyphi A colonies. Candidate S. Typhi and S. Paratyphi
A isolates were further subjected to standard biochemical tests for additional confirmation
[20].
Antimicrobial susceptibility testing
Antimicrobial susceptibility profiles were gauged by Kirby-Bauer disk diffusion tests. The
CLSI (Clinical and Laboratory Standards Institute) guidelines were used to evaluate zones of
inhibition for chloramphenicol, co-amoxiclav, co-trimoxazole, cefexime, ceftriaxone, azithro-
mycin, nalidixic acid, and ciprofloxacin[21]. Isolates displaying sensitivity to the tested antimi-
crobials as per the cut-off values in the CLSI guidelines were designated as susceptible and
those that were intermediate (I) or resistant (R) to the tested antimicrobials were designated as
non-susceptible.
Genome sequencing and SNP analysis
Briefly, DNA was extracted using the Wizard Genomic DNA Extraction Kit (Promega, Wis-
consin, USA), according to manufacturer’s instructions. Genomic DNA was then subjected to
indexed whole genome sequencing on an Illumina Hiseq 2500 platform at the Wellcome Trust
Sanger Institute to generate paired-end reads of 100–150 bp in length.
For analysis of SNPs in S. Typhi, Illumina reads were mapped to the reference genome
sequence of strain CT18[22] (accession AL515582) using the RedDog (V1beta.10.3) mapping
pipeline, available at https://github.com/katholt/RedDog. RedDog uses Bowtie (v2.2.9)[23] to
map reads to the reference sequence; uses SAMtools (v1.3.1)[24] to identify SNPs with phred
quality scores above 30; filters out those supported by <5 reads or with >2.5 times the average
read depth (representing putative repeated sequences), or with ambiguous consensus base
calls. For each SNP that passed these criteria in any one isolate, consensus base calls for the
SNP locus were extracted from all genomes (ambiguous base calls and those with phred quality
scores less than 20 were treated as unknowns and represented with a gap character). These
SNPs were used to assign isolates to previously defined lineages according to an extended S.
Typhi genotyping framework[25] (code available at https://github.com/katholt/genotyphi).
For phylogenetic analyses, SNPs with confident homozygous allele calls (i.e. phred score >20)
in>95% of the S. Typhi genomes (representing a ‘soft’ core genome of common S. Typhi
sequences) were concatenated to produce an alignment of alleles at 233,527 variant sites. SNPs
called in phage regions, repetitive sequences (354 kb; ~7.4% of bases in the CT18 reference
chromosome, as defined previously) or in recombinant regions identified using Gubbins
(v2.0.0)[26] were excluded, resulting in a final set of 2,187 SNPs identified in an alignment
length of 4,809,037 bp for the 198 novel Nepali S. Typhi isolates. SNP alleles from S. Paratyphi
A strain AKU_12601[27] (accession FM200053) were also included as an outgroup to root the
tree.
To provide regional context, genome data from: (i) a published study of mainly Nepali
adults[7] (n = 95), (ii) a global S. Typhi genome collection[25] (n = 1,221); were subjected to
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SNP calling and genotyping, resulting in an alignment of 12,216 SNPs for a total of 1,514 iso-
lates. Details and accession numbers of sequence data included in our analysis have been
included in S1 & S2 Tables. An additional analysis of all 261 H58 (genotype 4.3.1) from Nepal
was carried out in the same manner, resulting in an alignment of 631 SNPs.
To characterize and analyse the genomes of the 66 S. Paratyphi A strains, a similar bioinfor-
matic process was adopted using S. Paratyphi A AKU_12601[27] (accession no: FM200053) as
the reference genome to create an alignment with another selected 176 isolates from previous
studies[28–30], for global context resulting in an alignment of 5,277 SNPs in a total of 242 S.
Paratyphi isolates, with alleles from S. Typhi CT18[22] (accession no: AL515582) included as
an outgroup to root the tree.
Phylogenetic analysis
Maximum likelihood (ML) phylogenetic trees were inferred from SNP alignments using
RAxML (v8.1.23)[31], with the generalized time-reversible model, a Gamma distribution to
model site-specific rate variation (the GTR+ Γ substitution model; GTRGAMMA in RAxML),
and 100 bootstrap pseudo-replicates to assess branch support. The resulting trees were visual-
ized using Microreact[32] and the R package ggtree[33]. For visualization purposes, S. Typhi
isolates representing ‘outbreaks’ (defined as members of the same monophyletic clade, isolated
from the same study location in the same year) were manually thinned to a single
representative.
Temporal analysis
To investigate the temporal signal and emergence dates of antimicrobial resistance determi-
nants for Nepali S. Typhi 4.3.1, we used several methods. First, we used TempEst (v1.5)[34] to
assess temporal structure (i.e. whether the data have clocklike behaviour) by conducting a
regression of the root-to-tip branch distances of the Nepal H58/4.3.1 ML tree as a function of
the sampling time, using the heuristic residual mean squared method with the best-fitting root
selected. The resultant data were then visualized in R[35]. To estimate divergence times we
analysed the sequence data in BEAST2 (v2.4.7)[36]. We used both constant-coalescent popula-
tion size and Bayesian skyline tree priors, in combination with either a strict molecular clock
model or a relaxed (uncorrelated lognormal distribution) clock model to identify the model
that best fits the data. For the BEAST2 analysis the GTR+Γ substitution model was selected,
and the sampling times (tip dates) were defined as the year of isolation to calibrate the molecu-
lar clock. For all model and tree prior combinations, a chain length of 100,000,000 steps sam-
pling every 5000 steps was used[37]. The relaxed (uncorrelated lognormal) clock model, which
allows evolutionary rates to vary among branches of the tree together with the skyline demo-
graphic model, proved to be the best fit for the data. To assess the signal of these Bayesian esti-
mates we conducted a date-randomization test whereby sampling times were assigned
randomly to the sequences, and the analysis re-run 20 times[37,38]. These randomization tests
were conducted with the same ‘best fit’ models (uncorrelated lognormal clock and skyline
demographic). This test suggested that the data display ‘strong’ temporal structure[37].
For the final analysis reported here, 5 independent runs conducted with a chain length of
600,000,000 states, sampling every 300,000 iterations, were combined using LogCombiner
(v2.4.7)[36] following removal of the first 10% of steps from each as burn-in. Maximum-clade
credibility (MCC) trees were generated with ‘keep target heights’ specified for node heights
using TreeAnnotator (v2.4.7)[36,39]. The effective sample sizes from the combined runs were
estimated to be>200 for all reported parameters.
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In silico resistance plasmid and AMR gene analysis
The mapping based allele typer SRST2[40] was used to detect plasmid replicons and acquired
AMR genes and determine their precise alleles, by comparison to the ARG-Annot[41] and
ResFinder[42] databases (for AMR genes) and PlasmidFinder[41] (for plasmid replicons).
Where AMR genes were observed without evidence of a known resistance plasmid, raw read
data was assembled de novo with SPAdes (v3.7.1)[43] and Unicycler (v0.3.0b)[44] and exam-
ined visually using the assembly graph viewer Bandage (0.8.1)[45] to inspect the composition
and insertion sites of resistance-associated transposons. These putative transposon sequences
were annotated using Prokka (v1.11)[45] followed by manual curation, and visualized using
the R package genoPlotR[45]. SNPs in the QRDR of gyrA, gyrB, parC and parE genes, which
are associated with reduced susceptibility to fluoroquinolones in S. Typhi, S. Paratyphi A and
other species[7], were extracted from the whole genome SNP alignments.
Nucleotide sequence and read data accession numbers
Raw sequence data have been deposited in the European Nucleotide Archive under project
PRJEB14050; and individual accession numbers are listed in S1 and S2 Tables. Genome
assemblies for isolates RN2293 and RN2370 were deposited in GenBank.
Results
Paediatric enteric fever surveillance
Blood cultures were performed on 11,430 children with a suspected invasive bacterial infection
and requiring inpatient care with intravenous antibiotics and supportive care. Of these, 129
had blood cultures positive for the enteric fever agents S. Typhi (n = 102, 79%) or S. Paratyphi
A (n = 27, 21%). Relevant patient characteristics are reported in Table 1. Most cases of cul-
ture-confirmed enteric fever (n = 83, 64%) occurred between the hot and rainy months of
May and October. However, a substantial proportion (36%) of cases also occurred in colder
months, indicating perennial transmission. Children under 5 years of age accounted for 45%
of the disease burden among inpatients, with children under 2 years of age accounting for 18%
(Table 1). Clinical suspicion of enteric fever at presentation was significantly lower amongst
children under 2 years with culture-confirmed infection (13% vs. 52%, p = 0.0005 using
Table 1. Hospital based (inpatient) paediatric enteric fever surveillance.
Total blood cultures performed 11430
Total number of significant cultures 1048 (9.2%)
Total number of enteric fever pathogens 129 (1.1%)
S. Typhi 102 (0.9%)
S. Paratyphi A 27 (0.2%)
Age stratified characteristics of blood-culture positive enteric fever patients
Age groups <2 y 2–4 y 5–9 y 10–14 y
Number 23 35 39 31
Median age (years) 1.2 3.3 6.8 11.8
Male (%) 16 (70%) 23 (66%) 24 (62%) 18 (58%)
Median temperature at admission (C˚)
(range)
37.2 (36.7–
38.9)
38.3 (36.5–
39.9)
38.9 (36.1–
40.5)
37.2 (36.5–
39.2)
Median duration of admission (days) (range) 6 (2–23) 6.5 (1–19) 8 (2–36) 7.5 (3–20)
Enteric fever suspicion on admission (%) 3 (13%) 17 (49%) 19 (49%) 19 (61%)
https://doi.org/10.1371/journal.pntd.0006408.t001
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Fisher’s exact test; Table 1), highlighting the undifferentiated febrile nature of the disease even
in an endemic setting such as Nepal.
Phylogenetic structure of paediatric isolates from Nepal
The genomes of S. Typhi isolated from inpatient surveillance (n = 67) and a random selection
(every 10th isolate of S. Typhi and every 5th isolate of S. Paratyphi A) of isolates from outpa-
tients (n = 131) were sequenced and subjected to SNP genotyping and phylogenomic analysis
as described in Methods. The resulting phylogeny (S1 Fig) revealed the presence of 8 distinct
genotypes, each corresponding to a different subclade including 2.0.0 (N = 1, 0.5%) 2.2.0
(N = 10, 5%), 2.3.4 (N = 2, 1%), 3.2.2 (N = 6, 3%), 3.3.0 (N = 19, 9.6%), 3.3.1 (N = 3, 1.5%),
4.1.0 (N = 3, 1.5%), and 4.3.1 (N = 154, 77.8%). There was no significant association between
genotype and treatment status (outpatient vs. inpatient), clinical characteristics, period of iso-
lation (Fig 1A) or patient age (Fig 1B).
To place the novel paediatric isolates in context, we constructed a whole genome phylogeny
including other S. Typhi previously sequenced from adults in Nepal, and a global collection of
S. Typhi (Fig 2; an interactive version of the phylogeny and associated geographical data are
also available for exploration online at https://microreact.org/project/SJmU6dhlz). The novel
paediatric isolates clustered together with the adult isolates from Nepal, with no evidence of
certain genotypes circulating in children more so than adults. In comparison to global isolates,
Nepali isolates clustered with those from other regions in the Indian subcontinent, suggesting
ongoing transmission within the region (Fig 2); indeed 14% of the novel Nepali paediatric iso-
lates and 15% of the previously sequenced Nepali isolates were closest to an isolate from out-
side Nepal (majority from neighbouring India, Bangladesh or Pakistan), indicating frequent
pathogen transfer within the region.
We used the same approach to investigate genome variation amongst 66 S. Paratyphi A iso-
lated from inpatients (n = 17) and outpatients (n = 49) in Nepal, in the context of globally rep-
resentative genome diversity (Fig 3; interactive version available at https://microreact.org/
project/rk2ec5mWM). The Nepali S. Paratyphi A population was far less diverse than that of S.
Typhi; most belonged to lineage A and clustered into two distinct subgroups, which we desig-
nated sublineages A1 and A2 (see Fig 3). Akin to S. Typhi, the global context of S. Paratyphi A
also revealed close clustering with isolates from other regions in the Indian subcontinent and
China, which where S. Paratyphi A infections occur at high prevalence.
Antimicrobial resistance (AMR)
Amongst the paediatric isolates analysed in this study, most S. Typhi isolates (96%) and all S.
Paratyphi A were susceptible to traditional first-line antibiotics co-trimoxazole, ampicillin and
chloramphenicol (Fig 4). Most (86%) of S. Typhi and all the S. Paratyphi A of isolates were
non-susceptible to the fluoroquinolone ciprofloxacin (assessed by disk diffusion; Fig 4). MDR
was observed in six S. Typhi (3%) and no S. Paratyphi A. There were no differences in the fre-
quency of MDR or fluoroquinolone non-susceptibility between the paediatric inpatients and
outpatients (OR for MDR = 0.97, 95% CI 0.23–4.00; and OR for fluoroquinolone non-suscep-
tibility = 1.23, 95% CI 0.62–2.44).
Genetic determinants of AMR detected in the paediatric isolates are summarized in
Table 2. All S. Paratyphi A (besides the single lineage C4 isolate) carried the gyrA S83F muta-
tion responsible for nalidixic acid resistance and fluoroquinolone non-susceptibility. S. Typhi
isolates displaying fluoroquinolone non-susceptibility harboured known QRDR SNPs
(Table 2); these included isolates of genotypes 4.3.1 (gyrA SNPs), 3.3.0 (parE SNPs), and 3.3.1
(gyrA and parE SNPs, see S1 Fig). Sixteen S. Typhi isolates (all genotype 4.3.1) were QRDR
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‘triple mutants’, which are associated with failure to respond to fluoroquinolone therapy[7].
All MDR isolates (n = 6) belonged to S. Typhi genotype 4.3.1 and harboured the acquired
AMR genes catA, dfrA7, sul1, sul2, strA, strB and blaTEM-1, conferring resistance to chloram-
phenicol, co-trimoxazole, streptomycin and ampicillin. An additional genotype 4.3.1 isolate
carried a subset of four of these genes (sul2, strA, strAB and blaTEM-1) and displayed resistance
to ampicillin but was sensitive to co-trimoxazole and chloramphenicol (consistent with the
lack of dfr and cat genes). Acquired AMR genes were not detected amongst the S. Paratyphi A.
The full suite of seven acquired AMR genes are common amongst S. Typhi globally and are
typically located within a composite transposon, comprising Tn6029 (sul2, strA, strAB and bla-
TEM-1) and Tn21 (dfrA7, sul1) inserted within Tn9 (catA), which is most often carried on
IncHI1 plasmids[9]. Here, all MDR isolates carried this typical composite transposon, inserted
in the chromosome between genes STY3618 and STY3619 and associated with an 8 bp target
Fig 1. Nepal paediatric S. Typhi genotypes. (A) Genotypes observed per annum. (B) Genotypes observed per age in years. Individual S. Typhi genotypes are coloured
as described in the inset legend.
https://doi.org/10.1371/journal.pntd.0006408.g001
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site duplication (GGTTTAGA), consistent with integration mediated by the flanking IS1 trans-
posases of Tn9 (see Fig 5). The additional ampicillin resistant isolate carried only transposon
Tn6029, which was inserted directly into the chromosomal pseudogene slrP and associated
with an 8 bp target site duplication (TAGCTGAT), consistent with integration mediated by
the flanking IS26 transposases of Tn6029.
Evolutionary history of AMR S. Typhi 4.3.1 in Nepal
We constructed a dated phylogeny of all available S. Typhi 4.3.1 from Nepal, using BEAST2
(Fig 6, interactive version available at https://microreact.org/project/rJnfyOGxG). This analy-
sis yielded a local substitution rate of 0.8 SNPs per genome per year (95% highest posterior
density (HPD), 0.5–1.1) or 1.7x10-7 genome-wide substitutions per site per year (95% HPD,
1.1x10-7–2.4x10-7). The data showed strong temporal structure to support these results (see
Methods and S2 Fig), which were consistent with previous estimates for global S. Typhi 4.3.1
[10]. We estimated the most recent common ancestor (mrca) for all S. Typhi 4.3.1 in Nepal
existed circa 1993, similar to the mrca estimated globally for S. Typhi 4.3.1, which is predicted
to have emerged in neighbouring India[10].
Both of the previously described sublineages of S. Typhi 4.3.1 (I and II) were present
amongst the Nepali isolates, however (i) lineage II was far more common (67% vs. 10% of pae-
diatric isolates from this study; 68% vs 10% of isolates from other studies); and (ii) the lineages
were associated with different AMR patterns (Fig 6): lineage I was associated with MDR (59%
of lineage I vs 0 lineage II, p<1x10-15), while lineage II was associated with QRDR mutations
(99% of lineage II vs 50% of lineage I, p<1x10-15). The majority of isolates formed a local
monophyletic clade that was not detected in other countries in the global collection, indicative
of local clonal expansion in Nepal. The relative proportion of local S. Typhi infections caused
by lineage II increased after 2010 (40% pre-2010 vs 74% from 2011 onwards, p = 1x10-7),
Fig 2. Global population structure of Nepalese S. Typhi genotypes. (A) Global population structure of Non-H58 (4.3.1) Nepalese genotypes. (B) Global population
structure of H58 (4.3.1). Inner ring shows patient status. Branch colours indicate country/region of origin, as do the second ring and third rings from the inside. Fourth
ring from the inside indicates QRDR gyrA S83F mutation. Fifth ring from the inside indicates the number of additional gyrA and parC QRDR mutations. Outer ring
describes the presence of MDR. All rings and branches are coloured as per the inset legend. Branch lengths are indicative of the estimated number of substitutions rate
per variable site, and the tree was outgroup rooted with a S. Paratyphi A strain AKU_12601.
https://doi.org/10.1371/journal.pntd.0006408.g002
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suggesting clonal replacement of the MDR-associated lineage I with the expansion of the quin-
olone resistance-associated Lineage II over time.
Most of the ciprofloxacin resistant triple mutant isolates harboured gyrA S83F, gyrAD87N,
and parC S80I and formed a monophyletic subclade of lineage II, together with those previ-
ously reported as associated with gatifloxacin failure during the treatment trial in 2013–2014
[7]. We dated the mrca of this subclade to 2008 (95% HPD, 1998–2011; see Fig 6), and com-
parison to the global tree confirmed it most likely originated in India[7] and was introduced to
Nepal at least twice (see Fig 2B). We also identified a distinct ciprofloxacin resistant triple
mutant (harbouring gyrA S83F, gyrAD87G, and parC E84G) that was isolated from a five-year
old girl in 2011. This was also S. Typhi 4.3.1 lineage II but shared no particularly close relatives
in the Nepali or global collections (Fig 2B, Fig 6).
All isolates with acquired AMR genes belonged to Lineage I: one cluster of IncHI1 plasmid-
containing isolates (from a previous study conducted by Thanh et al 2016) with a mean tmrca
of 2004 (95% HPD, 1996–2007); two related clusters with the composite transposon inserted
in the chromosome after STY3618, with mean tmrca 2001 (95% HPD, 1995–2009); and one
Fig 3. Global population structure of S. Paratyphi A. Inner ring indicates patient status. Branch colours indicate country/region of origin, as do the second and third
rings from the inside. Fourth ring from the inside indicates QRDR gyrA S83F mutation. Fifth ring from the inside indicates the number of additional gyrA and parC
QRDR mutations. Outer ring describes the presence of MDR. All rings and branches are.
https://doi.org/10.1371/journal.pntd.0006408.g003
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cluster with Tn6029 inserted in the chromosome, with mean tmrca 2003 (95% HPD, 1997–
2010) (see Fig 6).
Discussion
These data show that enteric fever is a significant cause of illness amongst children in this
study (Table 1), the majority of which (86%) is non-susceptible to fluoroquinolones (Table 2).
Genomic analysis revealed substantial diversity within the local pathogen population (Figs 1 &
S1), with evidence of transfer of S. Typhi and S. Paratyphi A between Nepal and neighbouring
countries in South Asia (Figs 2 and 3), and intermingling of isolates from adults and children
consistent with transmission across age groups (Fig 2). Data from 2005–2006 suggested that
Fig 4. Bars are coloured as described in the inset legend. Susceptibility to Ampicillin, Chloramphenicol, Ciprofloxacin, Cotrimoxazole, Nalidixic acid, Cephalosporin,
Ceftriaxone, Cefixime, and Azithromycin were tested. No resistance to Azithromycin, Ceftriaxone, and Cefixime was observed.
https://doi.org/10.1371/journal.pntd.0006408.g004
Table 2. Genetic determinants of antimicrobial resistance in paediatric isolates from Nepal.
S. Typhi S. Paratyphi A
Total isolates 198 66
QRDR 164 (82.8%) 65 (98%)
gyrA S83F 143 (72%) 65 (98%)
gyrA S83F only 15 (7.6%) 0
gyrA S83F, gyrA D87N 16 (8.1%) 0
gyrA S83F, gyrA D87N, parC S80I 15 (7.6%) 0
gyrA S83F, gyrA D87N, parC E84G 1 (0.5%) 0
gyrA S83F, parC E84G 1 (0.5%) 0
gyrA S83F, parE A364V 5 (2.5%) 0
gyrA S83Y only 6 (3%) 0
parE A364V only 15 (7.6%) 0
Acquired AMR genes 7 (3.5%) 0
blaTEM-1, strAB, sul2 1 (0.5%) 0
catA1, dfrA7, sul1, blaTEM-1, strAB, sul2 (+ gyrA S83F) 4 (2%) 0
catA1, dfrA7, sul1, blaTEM-1, strAB, sul2 (+ gyrA S83Y) 2 (1%) 0
https://doi.org/10.1371/journal.pntd.0006408.t002
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younger children were more susceptible to a wider range of genotypes, a phenomenon attrib-
uted to a naïve immune response[5]. A decade later this tendency seems to have shifted
towards a more pathogen attributable trend as seen in Fig 1, which shows the S. Typhi 4.3.1
genotype is dominant regardless of the age and admission status of the host. This is consistent
with recent mathematical modelling of historical enteric fever patterns in this setting, which
identified the introduction of AMR 4.3.1, as well as an increase in migration of immunologi-
cally naïve 15–25 year olds from outside the Kathmandu Valley, as key drivers of the local
typhoid problem[46].
The high frequency of fluoroquinolone non-susceptibility is attributable to indiscriminate
and uncontrolled use of antimicrobials, which since the turn of the century have been used to
treat a range of infections common in the tropics in addition to enteric fever. Fluoroquiono-
lone non-susceptibility has been observed locally[7], associated with mutations in gyrA and
parC. Our data show that the problem of fluoroquinolone non-susceptible enteric fever in
Nepali children is mainly driven by two locally established pathogen variants, namely S. Typhi
4.3.1 (H58) lineage II harbouring the gyrA-S83F mutation (accounting for 50% of all enteric
fever, 57% of non-susceptible cases, and 66% of all S. Typhi) and S. Paratyphi A clade A har-
bouring the gyrA-S83F mutation (accounting for 25% of enteric fever, 28% of non-susceptible
cases, and 98% of all S. Paratyphi A). These strains have been present since the increase in
local case numbers began in 1997, and their arrival likely contributed to the increased disease
burden[46]. The universal fluroquinolone resistance demonstrated by the S. Paratyphi A pop-
ulation is of great concern particularly since a vaccine against paratyphoid fever is still in
development.
Notably, the fully fluoroquinolone resistant triple mutant S. Typhi strain that was first
detected in local adults in 2013 and halted the gatifloxacin treatment trial was still causing in
disease in Nepali children in 2015–2016, but was rare (2.5% of cases in 2015–16) and showed
no signs of displacing the wider population that carries only the gyrA-S83F mutation (65% of
cases in 2015–16). This lack of clonal replacement is consistent with the presence of a single,
distinct, triple mutant S. Typhi strain isolated from a 5-year old girl in 2011, which had no
descendant strains detected amongst the 126 cases examined from 2012–16, suggesting it has
not spread within the local human population. The lack of fully resistant S. Paratyphi A is also
Fig 5. Insertion sites of transposons observed in S. Typhi from Nepal. Genes and transposons are indicated according to the inset legend. TSD indicates target
site duplication, and Tn indicates transposon.
https://doi.org/10.1371/journal.pntd.0006408.g005
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notable. It has been shown that the gyrA-S83F mutation is not associated with a fitness cost in
S. Typhi and can be maintained in the absence of direct selection from fluoroquinolones; how-
ever our data suggest the same is not true of the triple mutants, hence limiting exposure to flu-
oroquinolones may at least control the spread of highly resistant strains.
Acquired resistance to other antimicrobials was rare, and in the paediatric population was
associated only with S. Typhi 4.3.1 lineage I strains carrying chromosomally integrated AMR
genes (Fig 6). This has not been reported previously in the local population, where MDR S.
Typhi has typically been associated with plasmids[47]. Here we identified at least two distinct
AMR gene integration events, that we estimate occurred contemporaneously with the MDR
plasmid circulating in the early 2000s (Fig 6). Although similar findings have also been
reported from S. Typhi strains in other neighbouring countries of India and Bangladesh[10],
this is the first description in strains from Nepal. Notably, in addition to the integration of the
typical S. Typhi MDR composite transposon mediated by IS1 transposase genes of Tn9, we
identified for the first time direct integration of Tn6029 into the S. Typhi chromosome (Fig 5),
mediated by IS26 and conferring ampicillin resistance in the absence of resistance to chloram-
phenicol or co-trimoxazole.
The findings of this study supplement our understanding of enteric fever in an endemic set-
ting. The occurrence of disease in the<5 years population is in agreement with the other
multi-centre data from South Asia, underscoring the importance of understanding the disease
transmission dynamics and preventive strategies in the vulnerable population. The magnitude
of disease occurrence in this age group is still an underestimation for several reasons; clinical
suspicion of enteric fever in this age group is generally low as evidenced in these data and this
trend has also been reported in other endemic regions[48]. The lack of clinical suspicion leads
to a lack of diagnostic testing, which is in itself, fraught with impediments to reliable results.
Blood culture, which is the feasible gold standard diagnostic performs poorly in this popula-
tion owing to the difficulty in obtaining the required amount of blood and due to pre-treat-
ment with antimicrobials prior to obtaining a blood sample. Despite the unique challenges
associated with diagnosing enteric fever in this population and the supposed lack of exposure,
reports from various endemic regions continue to reiterate the enormous burden of enteric
fever in pre-school children. Coupled with the problem of antimicrobial non-susceptibility
once a diagnosis is made, these difficulties highlight the urgent need for enteric fever vaccines
in children under 5. However vaccination options for these children are limited due to the
poor immunogenicity of the Vi polysaccharide vaccine in infants and the difficulty in adminis-
tering the Ty21a vaccine. Until the Vi conjugate vaccines are rolled out, in addition to improv-
ing sanitation and providing clean water, antimicrobial treatment remains the only short-term
option for containing the disease in this age group.
Cephalosporins are currently the first-line treatment for enteric fever in Nepal. We did not
detect any cephalosporin non-susceptibility in these isolates, however it is anticipated that
this will emerge via the acquisition of plasmid-encoded extended-spectrum beta-lactamase
genes, as has recently been observed among S. Typhi isolates from neighbouring India and
Pakistan[49–52]. Given the re-emergence of antimicrobial sensitivity to chloramphenicol
and co-trimoxazole as evidenced in this study, it may be logical to shift to these first-line drugs
for treating enteric fever; indeed there has already been a case report demonstrating efficacy of
co-trimoxazole treatment in the treatment of fluoroquinolone resistant H58 S. Typhi in this
setting[53]. We acknowledge the possibility that typhoidal Salmonella strains will acquire
Fig 6. BEAST2 maximum-clade credibility phylogenetic tree of Nepalese genotype 4.3.1 (H58) S. Typhi. Tips colours indicate outpatient (red)
vs. inpatient (blue) isolates. Acquisitions of molecular determinants of resistance are labelled.
https://doi.org/10.1371/journal.pntd.0006408.g006
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resistance to these antibiotics when re-introduced and the cycling of antimicrobials is seldom
sufficient to effectively prevent MDR in the long-term. However we propose this short-term
strategy might be commissioned until the typhoid conjugate vaccines are deployed, in order to
conserve cephalosporins and macrolides for the treatment of other tropical infections which
require higher-end antibiotics.
Our study has limitations as all isolates examined were from a single hospital based passive
surveillance programme and thus may not be representative of the disease trends in the wider
community. For inpatient isolates only stored samples were available (67 out of 102 for S.
Typhi and 17 out of 27 for S. Paratyphi A) for retrospective sequencing analysis, preventing
the use of a more formal random sampling technique; however we consider this is unlikely to
introduce sampling bias with respect to genotype, as genotypes were not known at the time of
storage and there is no reason to suspect particular genotypes would be more likely to have
been stored. Consistent with this expectation, the population structure observed here is com-
parable to that observed in previous studies suggesting that our opportunistic sampling is rea-
sonably representative of the population structure of paediatric typhoid in Nepal from 2008–
2016. Outpatient isolates were randomly sampled and expected to be representative, but these
were unable to be stratified by age, gender and admission information as outpatient data was
limited and did not include any patient level information.
Conclusion
These data highlight the burden of enteric fever in children in Nepal while demonstrating the
importance of laboratory and molecular surveillance in endemic regions. Those under the age
of 5 years contributed most to the burden of enteric fever among inpatients who represent the
severe spectrum of disease. The substantial contribution of those less than 2 years emphasize
the urgent need for the Vi conjugate vaccine in regions such as Nepal where antimicrobial
therapy is currently the main modality against enteric fever. Antimicrobial non-susceptibility
continues to complicate management protocols and calls for prudent strategies aimed at con-
serving the currently effective drugs while buying time for vaccine deployment. Finally, the
control of enteric fever in Nepal and South Asia requires a coordinated strategy given the
inter-country transmission that occurs with the Indian subcontinent. The Vi conjugate vac-
cines offer the real possibility of controlling enteric fever but eradication will only become a
possibility when the immunization strategy is supplemented by the provision of clean water
and improved sanitation.
Supporting information
S1 Fig. Population structure of paediatric S. Typhi in Nepal. Paratyphi A outgroup rooted
maximum likelihood phylogeny. Branch colours indicate the genotype (as labelled). Branch
lengths are indicative of the estimated number of substitution rate per variable site. The adja-
cent heatmap shows the presence of AMR genes (yellow) and QRDR mutations (green) pres-
ent in each isolate as described in the inset legend.
(TIF)
S2 Fig. Temporal analysis of Nepalese H58 (4.3.1). (A) Tempest regression of root-to-tip dis-
tance as (in the SNP alignment) a function of sampling time, with the root of the tree selected
using heuristic residual mean squared (each point represents a tip of the maximum likelihood
tree). The slope is a crude estimate of the substitution rate for the SNP alignment, the x-inter-
cept corresponds to the age of the root node, and the R2 is a measure of clocklike behaviour
(B) Date randomisation test with the left most box plot showing the posterior substitution rate
Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006408 April 23, 2018 15 / 19
estimate from the SNP alignment of the data with the correct sampling times, and the remain-
ing 20 boxplots showing the posterior distributions of the rate from replicate runs using ran-
domised dates. The data are considered to have strong temporal structure if the estimate with
the correct sampling times does not overlap with those from the randomisations.
(TIF)
S3 Fig. Direct comparison of S. Typhi genotype diversity detected in this study compared
to an earlier study of children at the same hospital (Holt et al, 2010; ref 5), stratified by age
group. Simpson’s diversity of S. Typhi genotypes is printed on each plot.
(TIF)
S1 Table. Characteristics S. Typhi isolates reported in this study.
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S2 Table. Characteristics S. Paratyphi isolates reported in this study.
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